Copeland Capital Management, LLC Albemarle Corp Transaction History

Copeland Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	BUY	$108.73 - $146.89 $72,196 - $97,534	664 Added 56.03%	1,849 $243,000
Q4 2023 Jan 19, 2024	SELL	$113.26 - $170.8 $524,280 - $790,633	-4,629 Reduced 79.62%	1,185 $171,000
Q3 2023 Oct 23, 2023	SELL	$162.63 - $243.44 $20,003 - $29,943	-123 Reduced 2.07%	5,814 $988,000
Q2 2023 Jul 14, 2023	BUY	$172.91 - $232.22 $163,399 - $219,447	945 Added 18.93%	5,937 $1.32 Million
Q1 2023 Apr 14, 2023	BUY	$208.49 - $290.15 $840,006 - $1.17 Million	4,029 Added 418.38%	4,992 $1.1 Million
Q3 2022 Oct 12, 2022	BUY	$195.82 - $307.05 $79,307 - $124,355	405 Added 72.58%	963 $255,000
Q2 2022 Jul 15, 2022	BUY	$187.76 - $270.92 $104,770 - $151,173	558 New	558 $117,000

919

104M

8.35M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $9.06B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Copeland Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Copeland Capital Management, LLC with notifications on news.